Abstract
We evaluated the usefulness of the recently developed Human Tumor Clonogenic Assay (HTCA) for chemosensitivity studies in childhood cancers. A total of 20 childhood cancer specimens containing 8 neuroblastomas, 4 malignant lymphomas, three hepatoblastomas, two rhabdomyosarcomas, two germinomas and one adrenal carcinoma were assayed. Overall, 65 per cent (13/20) of tumor cell specimens showed adequate colony forming ability to yield the sensitivity of anticancer drugs. The pattern ofin vitro sensitivity of a particular tumor to most anticancer drugs tested was not dissimilar to the clinical experiences of these agents. The overallin vitro response rate of childhood cancers to anticancer agents was 51 per cent. A retrospective analysis of this assay revealed a true positive rate of 57 per cent and a true negative rate of 100 per cent.
Similar content being viewed by others
References
Ebstein J, Preisler HD. A non clonogenic assay for the determination of the sensitivity of leukemic cells to chemotherapeutic agents. Eur J Cancer Clin Oncol 1983; 19: 1569–1574.
Selby PJ, Thomas JM, Peckham MJ. A comparison of the chemosensitivity of a primary tumor and its metastases using a human tumor xenograft. Eur J Cancer 1979: 15: 1425–1429.
Giovanella BC, Stehlin JS, Shepard FRC, Williams LJ. Correlation between response to chemotherapy of human tumors in patients and nude mice. Cancer 1983; 52: 1146–1152.
Weisenthal LM, Lalude AO, Miller JB.In vitro chemosensitivity of human cancer. Cancer 1983; 51: 1490–1496.
Nio Y, Inamoto T, Ohgaki K, Kan N, Hori T, Nakayama T, Yamazaki N, Hikasa Y. Ain vitro sensitivity assay of anticancer agents by measuring the inhibition rate of DNA synthesis of cancer cells-clinical study (in Japanese). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 1985; 86: 8–22 (English Abst.)
Bogden AE, Von Hoff DD. Comparison of the human tumor cloning and subrenal capsule assay. Cancer Res 1984; 44: 1087–1090.
Von Hoff DD. Send this patient's tumor for culture and sensitivity. N Eng J Med 1983; 308: 154–155.
Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197: 461–463.
Hamburger AW, Salmon SE. Primary bioassay of human melanoma stem cells. J Clin Invest 1977; 60: 846–854.
Hamburger AW, Salmon SE, Kim MB, Trent JM, Soehnlen BJ, Alberts DS, Schmidt HJ. Direct cloning of human ovarian carcinoma cells in agar. Cancer Res 1978; 38: 3438–3444.
Salmon SE, Von Hoff DD.In vitro evaluation of anticancer drugs with the human tumor stem cell assay. Seminars in Oncology 1981; 8: 377–385.
Greenberg BR, Salmon SE. Human tumor clonogenic assay in patients with unknown primary carcinomas. J Clin Oncol 1984; 2: 46–50.
Johns ME, Mills SE. Cloning efficiency. A possible prognostic indicator in squamous cell carcinoma of the head and neck. Cancer 1984; 52: 1401–1404.
Sarosdy ME, Lamm DL, Radwin HM, Von Hoff DD. Clonogenic assay andin vitro sensitivity testing of human urologic malignancies. Cancer 1982; 50: 1332–1338.
Salmon SE, Hamburger AW, Soehnlen BJ, Durie BG, Albert DS, Moon TE. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 1978; 298: 1321–1327.
Fleischman J, Hesten WBW, Fair WR. Renal cell carcinoma and clonogenic assay. J Urol 1983; 130: 1060–1062.
Mattox DE, Von Hoff DD, Clark GM, Aufdemorte TB. Factors that influence growth of head and neck carcinoma in the soft agar cloning assay. Cancer 1984; 53: 1736–1740.
Von Hoff DD, Foresth B, Metelman H, Harris G, Rowan S, Coltman CA. Direct cloning of human malignant melanoma in soft agar culture. Cancer 1982; 50: 696–701.
Alberts DS, Chen HSG, Salmon SE, Surwit EA, Young L, Moon TE, Meyskens FL. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay. Cancer Chemother Pharmacol 1981; 6: 279–285.
Von Hoff DD, Casper J, Bradley E, Trent JM, Hodach A, Reichert C, Makuch R, Altmann A. Direct cloning of neuroblastoma cells in soft agar culture. Cancer Res 1980; 40: 3591–3597.
Hiraki S, Ohi Y, Miyai T, Numata T, Kishimoto N, Miyamoto H, Kimura I. Anticancer drug sensitivity tested by tumor stem cell assay. Jpn J Cancer Clin 1984; 30: 1139–1145.
Von Hoff DD, Casper J, Bradley E, Sandbach J, Johns D, Makuch R. Association between human tumor colony forming assay result and response of an individual patient's tumor to chemotherapy. Am J Med 1981; 70: 1027–1032.
Tanigawa N, Hikasa Y, Kern DH. Clinical correlation of drug sensitivity in the human tumor clonogenic assay. Jpn J Cancer Clin Oncoll 1984; 30: 1153–1157.
Fan D, Morgan LR, Schneider C, Black H, Fan S. Cooperative evaluation of human tumor chemosensitivity in the soft agar assay and its clinical correlations. J Cancer Res Clin Oncol 1984; 109: 23–28.
Alonso K. Human tumor stem cell assay. A prospective clinical trial. Cancer 1984; 54: 2475–2479.
Bertelsen CA, Sontak VK, Mann BD, Korn EC, Kern DH. Chemosensitivity testing on human solid tumors. A review of 1582 assays with 258 clinical correlations. Cancer 1984; 53: 1240–1245.
Yasumuro S.In vitro colony assay of various solid tumors. (Nichidai Igaku Zasshi) 1984; 43: 197–208. (in Japanese)
Kurosu Y, Yasumuro S, Shibata M, Morita K. Human tumor clonogenic assay for digestive system cancers. Nihon Univ J Med 1985; 27: 39–45.
Shibata M. Human tumor clonogenic assay andin vitro sensitivity of human solid tumors to single chemotherapeutic agents and their combinations. Nihon Univ J Med 1985; 27: 183–196.
Mackintosh FR, Evans TL, Sikik BI. Methodologic problems in clonogenic assay of spontaneous human tumors. Cancer Chemother Pharmacol 1981; 6: 205–210.
Surwit EA. Pharmacologic studies of antitumor drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol 1981; 6: 253–264.
Ludwig R, Alberts DS. Chemical and histological stability of anticancer drugs in human tumor clonogenic assay. Cancer Chemother Pharmacol 1984; 12: 142–145.
Pavlik EJ, Kenady DE, Negel JR, Hanson MB, Donaldson ES, Casper J, Garret D, Smith D, Keaton K, Flanigan RC. Stability of doxorubicin in relation to chemosensitivity determinations. Loss of lethality and retention of antiprolifetive activity. Cancer Invest 1984; 2: 449–458.
Bosanquette AG. Stability of solutions of antineoplastic agents during preparations and storage forin vitro assays. Cancer Chemother Pharmacol 1985; 14: 83–85.
Franco R, Kraft T, Milley T, Popp M Mortello O. Storage of chemotherapy drugs for use in the human tumor stem cell assay. Int J Cell Cloning 1984; 2: 2–8.
Alberts DS, Salmon SE, Chen HSG, Moon TE, Young L, Surwit EA. Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol 1981; 6: 253–264.
Shimizu E, Saijo N, Kanzawa F, Hoshi A, Eguchi K, Shinkai T, Tominaga K, Sakaki Y, Fujita J, Nomori H, Futami H, Miyagawa N. Correlation between drug sensitivity determined by clonogenic assay and clinical effect of chemotherapy with primary lung cancer. Gann 1984; 75: 1030–1035.
Inoue K, Arakawa K, Miyamoto H, Adachi K, Mukaiyama K. Clony growth by malignant cells of cancer patients onin vitro colony assay. J Jpn Soc Cancer Ther 1984; 19: 1456–1463.
Sandbach J, von Hoff DD, Clark G, Cruz AB, Obrien M. Direct cloning of human breast cancer in soft agar culture. Cancer 1982; 50: 1315–1321.
Inoue K, Arakawa M, Ogawa M. Human tumor stem cell assay. (Gan to Kagaku Rhouhou) 1982; 9: 599–605. (in Japanese).
De Bernardi B, Comelli A, Cozzutto C, Lamedica C, Mori PG, Massimo L. Peptichemio in advanced neuroblastoma. Cancer Treat Rep 1978; 62: 811–817.
Bleyer WA, Krivit W, Chard RL Jr., Hammond D. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: A report from the children's cancer study group. Cancer Treat Rep 1979; 63: 977–981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shibata, M., Yasumuro, S., Ugajin, W. et al. In vitro growth and chemosensitivity studies of childhood cancers using clonogenic assay. The Japanese Journal of Surgery 16, 126–132 (1986). https://doi.org/10.1007/BF02471082
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02471082